Tuo, Liu & Huang
FULL PAPER
above obtained ketone in dry THF (8 mL) under N2 at-
mosphere, Zn (195 mg, 3.0 mmol) was added. The
mixture was heated to reflux, and a solution of ethyl-
2-bromomethacrylate (0.2 mL, 1.5 mmol) in dry THF (2
mL) was added. After 1 h of refluxing, the ketone dis-
appeared as indicated by TLC analysis. The mixture was
filtered through Celite and the filtrate was concentrated
under vacuum. The residue was dissolved in CH2Cl2 (10
mL) and washed with a saturated NH4Cl solution. The
aqueous phase was extracted with CH2Cl2 (5 mL×2).
The combined organic layers were dried over anhydrous
Na2SO4, filtered and concentrated in vacuum. Purifica-
tion of the crude material by flash column chromatog-
raphy on silica gel eluting with EtOAc/PE (2∶1) af-
forded compound 16 (445 mg, yield: 91%) as a white
solid. m.p. 120-128 ℃ (MeOH); [α]2D0 −71 (c 1.0,
calcd for [C13H17NO4+Na+]: 274.1050; found 274.1053.
((2R,3'S,8a'S)-4-Methylene-5,5'-dioxooctahydro-1'H,
3H-spiro[furan-2,8'-indolizine]-3'-yl)methyl-4-nitro-
benzenesulfonate (18)
To an ice-bath cooled solution of 17 (30 mg, 0.13
mmol) in CH2Cl2 (6 mL) were added successively
DMAP (cat.), 4-nitrobenzene-1-sulfonyl chloride (86
mg, 0.39 mmol) and Et3N (0.07 mL, 0.52 mmol). After
being stirred at room temperature overnight, the reaction
was quenched with a saturated aqueous NaHCO3 (2 mL)
and water (1 mL) at 0 ℃. The organic layer was sepa-
rated and the aqueous layer was extracted with CH2Cl2
(3 mL×3). The combined organic layers were dried
over anhydrous Na2SO4, filtered and concentrated under
reduced pressure. The residue was purified by flash
chromatography on silica gel eluting with EtOAc/PE
(6∶1) to afford compound 18 (50 mg, yield 96%) as a
white solid. m.p. 160-161 ℃ (MeOH); [α]2D0 −56 (c
0.4, CHCl3); 1H NMR (500 MHz, CDCl3) δ: 1.82-1.95
(m, 2H), 1.55-1.66 (m, 1H), 1.97-2.16 (m, 3H), 2.38
(dd, J=18.4, 6.2 Hz, 1H), 2.56 (ddd, J=18.4, 12.0, 7.4
Hz, 1H), 2.80 (dt, J=17.5, 2.7 Hz, 1H), 2.88 (dt, J=
17.5, 2.8 Hz, 1H), 3.66 (dd, J=10.9, 5.0 Hz, 1H), 4.18
(dd, J=10.1, 2.3 Hz, 1H), 4.21-4.30 (m, 1H), 4.63 (dd,
J=10.1, 3.9 Hz, 1H), 5.72 (t, J=2.5 Hz, 1H), 6.30 (t,
J=2.8 Hz, 1H), 8.05-8.10 (m, 2H), 8.36-8.41 (m,
2H); 13C NMR (125 MHz, CDCl3) δ: 24.2 (CH2), 25.0
(CH2), 28.1 (CH2), 33.4 (CH2), 36.4 (CH2), 56.1 (CH),
35.1 (CH2), 65.7 (CH), 71.2 (CH2), 78.5 (C), 124.1
(CH2), 124.6 (CH), 129.3 (CH), 133.1 (C), 141.4 (C),
151.0 (C), 168.1 (CO), 168.8 (CO); IR (film) vmax: 3104,
2963, 2917, 2847, 1759, 1640, 1630, 1530, 1451, 1404,
1352, 1271, 1185, 1095 cm−1. HRMS (ESI) calcd for
[C19H20N2O8S+Na+]: 459.0833; found 459.0836.
1
CHCl3); H NMR (500 MHz, CDCl3) δ: 1.05 (s, 9H),
1.59-1.69 (m, 1H), 1.83-1.92 (m, 2H), 1.97-2.10
(m, 4H), 2.37 (dd, J=18.2, 6.3 Hz, 1H), 2.57 (ddd, J=
18.2, 12.5, 7.0 Hz, 1H), 2.73 (dt, J=17.4, 3.0 Hz, 1H),
2.83 (dt, J=17.4, 2.8 Hz, 1H), 3.65 (dd, J=10.7, 5.6
Hz, 1H), 3.76 (dd, J=10.3, 2.3 Hz, 1H), 4.15 (dd, J=
10.3, 4.0 Hz, 1H), 4.23—4.30 (m, 1H), 5.69 (t, J=2.6
Hz, 1H), 6.29 (t, J=3.0 Hz, 1H), 7.33—7.42 (m, 6H),
7.58—7.62 (m, 1H); 13C NMR (125 MHz, CDCl3) δ:
19.4 (C), 24.0 (CH2), 25.3 (CH2), 27.0 (CH), 28.2 (CH2),
30.0 (CH2), 33.6 (CH2), 36.6 (CH2), 58.4 (CH), 64.3
(CH2), 66.0 (CH), 78.8 (C), 123.6 (CH2), 127.69 (CH),
127.71 (CH), 129.7 (CH), 129.8 (CH), 133.5 (C), 133.6
(C), 135.49 (CH), 167.1 (CO), 169.0 (CO); IR (film)
v
max: 3070, 2959, 2930, 1769, 1582, 1426, 1267, 1066
cm−1. HRMS (ESI) calcd for [C29H35NO4Si+Na+ ]:
512.2228; found 512.2230.
(2R,3'S,8a'S)-3'-(Hydroxymethyl)-4-methylenetetra-
hydro-1'H,3H-spiro[furan-2,8'-indolizine]-5,5'(4H,
8a'H)-dione (17)
Results and Discussion
To a cooled solution (0 ℃) of compound 16 (110
mg, 0.23 mmol) in anhydrous THF (2 mL) under N2
was added Py•HF (0.21 mL, 2.3 mmol) dropwise. After
being stirred at room temperature for 24 h, the mixture
was concentrated under reduced pressure. The residue
was purified by flash chromatography on silica gel
eluting with EtOAc/MeOH (15∶1) to afford compound
17 (52 mg, yield: 92%) as a white solid. m.p. 145-146
The SmI2-mediated[10] reductive coupling-lactoniza-
tion method[11] was first investigated. The hydroxyin-
dolizidinone core 5[7] found in sessilifoliamide J was
chosen as a model substrate, which was converted to
ketone 6 by Ley oxidation[12] (TPAP/NMO/4 Å MS). To
confirm the syn/anti diastereoselectivity (C-9/C-9a)[8] in
the subsequent spirolactonization, the SmI2-mediated
coupling of ketone 6 with methyl acrylate was first un-
dertaken. The 11-demethyl derivative of sessilifoliamide
J was obtained as a diastereomeric mixture (10 and 11)
1
℃ (MeOH); [α]2D0 −42 (c 0.5, CHCl3); H NMR (500
MHz, CDCl3) δ: 1.34-1.44 (m, 1H), 1.55-1.66 (m,
1H), 1.83 (td, J=12.1, 6.1 Hz, 1H), 1.98-2.14 (m, 3H),
2.51 (ddd, J=18.5, 5.4, 3.0 Hz, 1H), 2.62 (ddd, J=18.5,
11.7, 7.8 Hz, 1H), 2.79 (dt, J=17.5, 2.7 Hz, 1H), 2.87
(dt, J=17.5, 2.7 Hz, 1H), 3.50 (dd, J=11.6, 7.7 Hz,
1H), 3.63 (dd, J=11.5, 5.1 Hz, 1H), 3.68 (d, J=11.5 Hz,
1H), 5.35 (s, 1H), 5.70 (t, J=2.5 Hz, 1H), 6.28 (t, J=
2.8 Hz, 1H), 7.58-7.62 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ: 24.8 (CH), 25.4 (CH), 28.1 (CH), 33.2 (CH),
36.4 (CH), 62.0 (CH2), 66.0 (CH2), 67.0 (CH), 60.0
(CH), 78.6 (C), 123.0 (CH), 133.2 (C), 168.8 (CO),
170.3 (CO); IR (film) vmax: 3407, 2917, 2849, 1767,
1620, 1452, 1414, 1289, 1215, 1069 cm−1. HRMS (ESI)
1
in a ratio of 25∶75 (determined by H NMR) (Scheme
2). The two diastereomers could be separated by prepa-
rative HPLC. The stereochemistries of the two diastereo-
mers were determined by NOESY experiments. The
observed NOESY correlations between H10β↔H9a↔
H10α in compound 11 (Figure 2) allowed an unambigu-
ous assignment of the stereochemistry of 11 as anti
(C-9/C-9a). Thus the major diastereomer is 9-epi-11-
demethylsessilifoliamide J (11) and the minor di-
astereomer is 11-demethylsessilifoliamide J (10). The
results are in agreement with our previous observation
58
© 2013 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2013, 31, 55—62